1. Home
  2. DCTH vs PSTL Comparison

DCTH vs PSTL Comparison

Compare DCTH & PSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • PSTL
  • Stock Information
  • Founded
  • DCTH 1988
  • PSTL 2018
  • Country
  • DCTH United States
  • PSTL United States
  • Employees
  • DCTH N/A
  • PSTL N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • PSTL Real Estate Investment Trusts
  • Sector
  • DCTH Health Care
  • PSTL Real Estate
  • Exchange
  • DCTH Nasdaq
  • PSTL Nasdaq
  • Market Cap
  • DCTH 387.2M
  • PSTL 320.0M
  • IPO Year
  • DCTH N/A
  • PSTL 2019
  • Fundamental
  • Price
  • DCTH $10.91
  • PSTL $12.95
  • Analyst Decision
  • DCTH Strong Buy
  • PSTL Strong Buy
  • Analyst Count
  • DCTH 4
  • PSTL 1
  • Target Price
  • DCTH $21.50
  • PSTL $15.50
  • AVG Volume (30 Days)
  • DCTH 375.2K
  • PSTL 107.0K
  • Earning Date
  • DCTH 11-08-2024
  • PSTL 11-04-2024
  • Dividend Yield
  • DCTH N/A
  • PSTL 7.13%
  • EPS Growth
  • DCTH N/A
  • PSTL N/A
  • EPS
  • DCTH N/A
  • PSTL 0.08
  • Revenue
  • DCTH $22,644,000.00
  • PSTL $72,005,000.00
  • Revenue This Year
  • DCTH $1,605.13
  • PSTL N/A
  • Revenue Next Year
  • DCTH $111.67
  • PSTL $12.18
  • P/E Ratio
  • DCTH N/A
  • PSTL $169.53
  • Revenue Growth
  • DCTH 945.91
  • PSTL 16.87
  • 52 Week Low
  • DCTH $3.43
  • PSTL $12.94
  • 52 Week High
  • DCTH $13.30
  • PSTL $15.15
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 57.95
  • PSTL 22.43
  • Support Level
  • DCTH $11.67
  • PSTL $13.73
  • Resistance Level
  • DCTH $13.30
  • PSTL $13.91
  • Average True Range (ATR)
  • DCTH 0.73
  • PSTL 0.21
  • MACD
  • DCTH 0.01
  • PSTL -0.07
  • Stochastic Oscillator
  • DCTH 34.60
  • PSTL 0.74

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

About PSTL Postal Realty Trust Inc.

Postal Realty Trust Inc is an internally managed real estate corporation that owns and manages properties leased to the United States Postal Service, or the USPS. Its objective is to create stockholder value by generating risk-adjusted returns through expanding its portfolio of owned and managed postal properties leased to the USPS. The majority of the revenue is generated from the rental income received.

Share on Social Networks: